Brief: Shenzhen Neptunus Interlong Bio-Technique Expects A Decrease In Profit Attributable For HY
30/07/2018 16:08
July 30 (Reuters) - Shenzhen Neptunus Interlong
Bio-technique Co Ltd 8329.HK :
* EXPECTED TO RECORD A DECREASE OF NO MORE THAN 50% IN
PROFIT
ATTRIBUTABLE FOR HY
* EXPECTED RESULT DUE TO SUBSTANTIAL INCREASE IN SALES
EXPENSES
Source text for Eikon: ID:nHKS8q2yJT
Further company coverage: 8329.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million